ARTICLE | Clinical News
Neumega oprelvekin: Marketed
November 6, 2000 8:00 AM UTC
In 4 patients with chronic hepatitis C virus (HCV) infection, Neumega treatment improved platelet levels when given either to prevent or to treat thrombocytopenia induced by therapy with interferon an...